Clinical Trials Browser

Phase 2 × Terminated × Other neoplasm × Clear all

NCT02701517 2017-12-29

Cyclosporine Plus Methotrexate or Alemtuzumab

Phase 2 Terminated

LymphoidOther neoplasm

Unrecognized Condition: Mature B or T-cell Neoplasm

NCT00118066 2015-05-27

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

Phase 2 Terminated

GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

NCT00942422 2015-03-27

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Phase 2 Terminated

8 enrolled 5 charts

Other neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

NCT00588822 2014-05-06

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Phase 2 Terminated

21 enrolled 11 charts

Monoclonal Gammopathy of Undetermined Significance, Precancerous Conditions

NCT00611650 2012-03-09

Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia

Phase 2 Terminated

Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions, Tobacco Use Disorder